The global urology surgical instrument market is forecasted to attain revenue of $13.7 billion by 2023, according to P&S Market Research.
The market is majorly being driven by increasing prevalence of urinary tract infections (UTIs) in women, surging geriatric population, and rising prevalence of benign prostatic hyperplasia (BPH) procedures.
Insights into market segments
On the basis of product, the market has been categorized into consumables and accessories, urology endoscopes, endovision systems, and peripheral instruments. The consumables and accessories category is predicted to lead the urology surgical instrument market, both in terms of size and growth. The category contributed a 45.3% share in the global market in 2017 and is expected to progress at a CAGR of 9.1% during the forecast period. This leading position is mainly attributable to the high use of guidewires, stone basket, stents, catheters and dilator sets in urology surgery.
Consumables and accessories are further classified into guidewires, stone basket/retrieval device and extractor, catheter, stent, biopsy device, fluid flushing device, connecting tube, clamp, overtube, and distal attachment, dilator set and ureteral access sheath, drainage bag, surgical dissectors, needle forceps and needle holders, and other products. Among these, guidewires led the urology surgical consumables and accessories market and generated a revenue of $818.6 million in 2017. This can be ascribed to its features like smooth tracking, easy advancement, maximum maneuverability, and precise control during surgical procedures. This adds to the growth of the urology surgical instrument market, globally.
Browse report overview with 86 tables and 53 figures spread through 152 pages and detailed TOC on "Urology Surgical Instrument Market by Product (Consumables & Accessories, Urology Endoscope, Endovision System, Peripheral Instrument), by Application (Chronic Kidney Disease (CKD), Urinary Stone, Benign Prostatic Hyperplasia (BPH), Urinary Incontinence and Pelvic Organ Prolapse (UI & POP), Oncology), by Geography (U.S., U.K., Germany, France, Japan, China, India, Brazil) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023" at:https://www.psmarketresearch.com/market-analysis/urology-surgical-instrument-market
These surgical instruments find application for the treatment of chronic kidney disease (CKD), urinary stone, BPH, urinary incontinence (UI) and pelvic organ prolapse (POP), oncology and other disorders (erectile dysfunction and hernia). Urology surgical instruments are widely used for the treatment of CKDs due to their increasing prevalence globally as compared to other disorders, and held the largest share in the urology surgical instrument market. According to Centers for Disease Control and Prevention (CDC), 30 million people or 15% of U.S. adults were estimated to have CKDs in 2017.
APAC to register the fastest growth during the forecast period
Asia-Pacific (APAC) is expected to be the fastest growing urology surgical instrument market during the forecast period, with a CAGR of 9.4%. This can be attributed to increasing awareness about urological disorders, leading medical tourism destinations, and growing healthcare industry in the region.
Due to increasing GDP, the countries in the region are witnessing growing demand of these surgical instruments. According to the World Bank, the GDP per capita of India increased from $1,345.8 in 2010 to $1,709.4 in 2016. A similar trend has been observed for other developing countries as well, such as Papua New Guinea, Philippines, and Indonesia, thus leading to the growth of the APAC urology surgical instrument market.
The increasing number of conferences further assist the growth of the APAC urology surgical instrument industry. Conference Series LLC company organizes conferences for various company’s delegates and students. For instance, it is going organize the 15th international conference on nephrology and hypertension from 22nd April-23rd April 2019 in Kuala Lumpur, Malaysia. This event is expected to include topics such as clinical nephrology, CKDs, dialysis and recent renal therapies, nephrology and hypertension, nephrotic syndrome, and renal failure. Thus, the increase in conferences is expected to create awareness among urologic surgeons to understand kidney disorders more practically.
Market players embracing acquisitions as key growth strategy
Globally, key players in the urology surgical instrument industry are acquiring other firms to attain a higher position in the market. For instance, in March 2018, Boston Scientific Corporation announced that it acquired EMcision Limited, a developer of medical devices in the U.K. and Canada. The acquisition would expand the Boston Scientific Endoscopy portfolio to include the HabibTM EndoHPB probe, a novel endoscopic bipolar radiofrequency device, which coagulates tissue in the gastrointestinal (GI) tract.
In December 2017, Coloplast A/S entered into a definitive agreement to acquire SAS Lilial (Lilial), a privately owned French catheter and ostomy supplier, for a cash consideration of $41.7 million (€35.5 million). The transaction was closed in January 2018. The acquisition was aimed at providing further access to payers and strengthening Coloplast’s position and offerings in France. Acquisitions taking place in this industry boost the growth of the urology surgical instrument market.
Some of the other key players, other than those mentioned above, operating in the urology surgical instrument industry are Karl Storz GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, Cook Medical LLC, Medtronic plc, Stryker Corporation, Teleflex Incorporated, CONMED Corporation, and CooperSurgical Inc.
GLOBAL UROLOGY SURGICAL INSTRUMENT MARKET SEGMENTATION
Market Segmentation by Product
Market Segmentation by Application
Market Segmentation by Geography